Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences’ COVID-19 Neutralizing Antibodies

The paper, titled A human neutralizing MAb targeting the receptor binding site of SARS-CoV-2 (Shi et al.